BNO 1095

Vitex agnus-castus · Bionorica SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNO 1095, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea [Phase 3]